Based just north of Boston, PIRC is the U.S. hub of PharmaEssentia’s drug discovery and development efforts. Our team identifies and advances scientific breakthroughs that make new therapies for rare cancers possible, helping to improve patients’ health and quality of life. We’re currently focused on three main areas of drug discovery.
We fill the PharmaEssentia pipeline with first-and best-in-class PEGylated cytokines across indications, starting in hematology, oncology, and immunology.
Learn More
We investigate new modalities backed by strong data, including those that target novel checkpoints regulating the immune responses relevant to oncology and immunology.
Learn More
With our in-house expertise in antibody discovery and protein conjugation technology, we are uniquely positioned to discover novel, innovative ADCs for cancer treatment.
Learn More
PIRC is growing fast. We are actively seeking scientists, associates, and other professionals with drug discovery experience who are excited about doing cutting-edge science that provides doctors with new tools for treating rare cancers and autoimmune conditions.
PharmaEssentia Innovation Research Center
Bedford, MA
781-691-3930
